Literature DB >> 4644630

Cell fusion by canine distemper virus-infected cells.

A M Rankin, L E Fisher, R H Bussell.   

Abstract

AV3 cells (continuous human amnion) infected with the Onderstepoort strain of canine distemper virus produced cell fusion within 2 to 5 hr when added to AV3 cell monolayers. An apparent requirement for intact, infected cells was demonstrated by showing that (i) frozen-and-thawed infected cells failed to induce fusion, (ii) infected cells frozen in the presence of glycerol retained their ability to induce fusion, (iii) infected cells subjected to swelling in hypotonic buffer and homogenization lost their ability to fuse cells, and (iv) semipurified and concentrated virus preparations with infectivity titers as high as 10(7.5) mean tissue culture doses per ml failed to induce fusion within 5 hr. Preparations of intact, infected cells had a mean log(10) ratio of infectivity to fusion activity of 3.6. Treatment with beta-propiolactone rendered the active preparations free from detectable infectivity while they retained their ability to cause cell fusion. Cycloheximide did not block the formation of syncytia in assay cells. This type of cell fusion was neutralized by canine distemper virus immune antisera, and measles virus immune sera showed a slight degree of cross-neutralization. Other cell lines, HEp-2, MA 139 (embryonic ferret lung), MA 104 (embryonic rhesus monkey kidney), and Vero (African green monkey kidney) were also susceptible.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4644630      PMCID: PMC356599     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Effect of beta-propiolactone, ultraviolet irradiation, and formalin on sendai virus cell-fusion factor.

Authors:  F A Pedreira; N M Tauraso
Journal:  Arch Gesamte Virusforsch       Date:  1969

2.  Canine distemper virus in ferret, dog and bovine kidney cell cultures.

Authors:  R H Bussell; D T Karzon
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  Studies on Sendai virus cell fusion factor.

Authors:  M A Guggenheim; S Tyrrell; A S Rabson
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

4.  Poliovirus replication and cytopathogenicity in monolayer hamster cell cultures fused with beta propiolactone-inactivated Sendai virus.

Authors:  J M Neff; J F Enders
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

5.  An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5.

Authors:  R W Compans; K V Holmes; S Dales; P W Choppin
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

6.  Development of measles virus in vitro.

Authors:  T Nakai; F L Shand; A F Howatson
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

7.  Cell fusion by various strains of Newcastle disease virus and their virulence.

Authors:  A Kohn; P Fuchs
Journal:  J Virol       Date:  1969-05       Impact factor: 5.103

8.  Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus.

Authors:  M A Bratt; W R Gallaher
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

9.  Studies on the inactivation of cell-fusing property of Newcastle disease virus by phospholipase A.

Authors:  A Kohn; C Klibansky
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

10.  On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types.

Authors:  K V Holmes; P W Choppin
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  2 in total

1.  Visna virus-induced fusion of continous simian kidney cells.

Authors:  M J August; D H Harter
Journal:  Arch Gesamte Virusforsch       Date:  1974

2.  Conditional dependence of fusion from within and other cell membrane alterations by Newcastle disease virus.

Authors:  W R Gallaher; M A Bratt
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.